Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
227.86
-0.04 (-0.02%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Quest Diagnostics Revenue
Quest Diagnostics had revenue of $3.04B in the quarter ending June 30, 2026, with 10.21% growth. This brings the company's revenue in the last twelve months to $11.56B, up 9.87% year-over-year. In the year 2025, Quest Diagnostics had annual revenue of $11.04B with 11.78% growth.
Revenue (ttm)
$11.56B
Revenue Growth
+9.87%
P/S Ratio
2.18
Revenue / Employee
$202,807
Employees
57,000
Market Cap
25.15B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.04B | 1.16B | 11.78% |
| Dec 31, 2024 | 9.87B | 620.00M | 6.70% |
| Dec 31, 2023 | 9.25B | -631.00M | -6.38% |
| Dec 31, 2022 | 9.88B | -905.00M | -8.39% |
| Dec 31, 2021 | 10.79B | 1.35B | 14.32% |
| Dec 31, 2020 | 9.44B | 1.71B | 22.15% |
| Dec 31, 2019 | 7.73B | 195.00M | 2.59% |
| Dec 31, 2018 | 7.53B | 129.00M | 1.74% |
| Dec 31, 2017 | 7.40B | 188.00M | 2.61% |
| Dec 31, 2016 | 7.21B | -279.00M | -3.72% |
| Dec 31, 2015 | 7.49B | 58.00M | 0.78% |
| Dec 31, 2014 | 7.44B | 289.00M | 4.04% |
| Dec 31, 2013 | 7.15B | -237.00M | -3.21% |
| Dec 31, 2012 | 7.38B | -9.00M | -0.12% |
| Dec 31, 2011 | 7.39B | 131.88M | 1.82% |
| Dec 31, 2010 | 7.26B | -195.12M | -2.62% |
| Dec 31, 2009 | 7.46B | 205.80M | 2.84% |
| Dec 31, 2008 | 7.25B | 544.54M | 8.12% |
| Dec 31, 2007 | 6.70B | 436.25M | 6.96% |
| Dec 31, 2006 | 6.27B | 811.93M | 14.88% |
| Dec 31, 2005 | 5.46B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IQVIA Holdings | 16.63B |
| Labcorp Holdings | 14.14B |
| ICON Public Limited Company | 8.27B |
| Agilent Technologies | 7.23B |
| IDEXX Laboratories | 4.45B |
| Illumina | 4.39B |
| Mettler-Toledo International | 4.09B |
| Waters | 3.77B |
DGX News
- 19 hours ago - Quest Diagnostics price target raised to $265 from $245 at BofA - TheFly
- 20 hours ago - Quest Diagnostics price target raised to $232 from $220 at UBS - TheFly
- 21 hours ago - Quest Diagnostics price target raised to $260 from $235 at Mizuho - TheFly
- 21 hours ago - Quest Diagnostics price target raised to $255 from $236 at Baird - TheFly
- 1 day ago - Quest Diagnostics price target raised to $250 from $230 at Barclays - TheFly
- 1 day ago - Quest Diagnostics price target raised to $245 from $225 at Jefferies - TheFly
- 1 day ago - Quest Diagnostics Earnings Call Transcript: Q2 2026 - Transcripts
- 1 day ago - Quest Diagnostics Earnings release: Q2 2026 - Filings